Muscular dystrophy. G71.00 - Muscular dystrophy, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Muscular dystrophy with proximal muscles involvement Approved muscular dystrophy diagnosis by neurologist Ability to walk 10 meters without help To be volunteer for intervention
Exclusion criteria
Exclusion criteria: Using drugs affecting muscular strength Acute myositis Orthopedic problems limiting patient movements Other neurologic or systemic disease involving muscles Skin lesion or infection at the site of electrode placements History of symptomatic cardiomyopathy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Muscle strength. Timepoint: before intervention, after 6 weeks intervention, 3 months post intervention. Method of measurement: dynamometer. | — |
Secondary
| Measure | Time frame |
|---|---|
| Motor Function. Timepoint: before, 6 weeks and 3 months post intervention. Method of measurement: The Motor Function Measure-32 scale.;Fatigue severity. Timepoint: before, 6 weeks and 3 months post intervention. Method of measurement: Fatigue severity scale.;Balance. Timepoint: before, 6 weeks and 3 months post intervention. Method of measurement: Berg Balance Scale.;Quality of life. Timepoint: before, 6 weeks and 3 months post intervention. Method of measurement: SF-36 for quality of life evaluation. | — |
Countries
Iran (Islamic Republic of)
Contacts
Tehran University of Medical Sciences